Insulin-like growth factor I differentially regulates the expression of HIRF1/hCAF1 and BTG1 genes in human MCF-7 breast cancer cells

International Journal of Molecular Medicine

Volumn 18, Issue 1, 2006, Pages 129-139

  Vadgama, Jaydutt V ^a,b   Scuric, Zorica ^a   Chakrabarti, Rita ^a   Marzo, Ehrnad ^a   Shen, Dejun ^a   Wu, Yanyuan ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; BTG1; Human CCR4 associated factor 1 gene; Human IGF I regulated factor 1; Insulin like growth factor I; MCF 7

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4-(4-FLUOROPHENYL)-2-(4-HYDROXYPHENYL)-5-(4-PYRIDYL)IMIDAZOLE; BTG1 PROTEIN, HUMAN; CHROMONE DERIVATIVE; CNOT8 PROTEIN, HUMAN; ENZYME INHIBITOR; FLAVONOID; IMIDAZOLE DERIVATIVE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MORPHOLINE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PYRIDINE DERIVATIVE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BREAST TUMOR; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PATHOLOGY; SEQUENCE HOMOLOGY; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID SEQUENCE; BASE SEQUENCE; BLOTTING, NORTHERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMONES; ENZYME INHIBITORS; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMIDAZOLES; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; MORPHOLINES; NEOPLASM PROTEINS; PYRIDINES; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 33748199698     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.18.1.129     Document Type: Article

References (55)

1. Elledge SJ and Harper JW: Cdk inhibitors: on the threshold of checkpoints and development. Curr Opin Cell Biol 6: 847-852, 1994.
2. Lee AV and Yee D: Insulin-like growth factors and breast cancer. Biomed Pharmacother 49: 415-442, 1995.
3. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME and Rosen N: Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50: 48-53, 1990. (Pubitemid 20029992)
4. Dey BR, Frick K, Lopaczynski W, Nissley SP and Furlanetto RW: Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10. Mol Endocrinol 10: 631-641, 1996. (Pubitemid 26176271)
5. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MG Jr, Glasheen E, Lane WS, Pierce JH and White MF: Role of IRS-2 in insulin and cytokine signalling. Nature 377: 173-177, 1995.
6. Beitner-Johnson D and Le Roith D: Insulin-like growth factor-I stimulates tyrosine phosphorylation of endogenous c-Crk. J Biol Chem 270: 5187-5190, 1995.
7. O'Neill TJ, Rose DW, Pillay TS, Hotta K, Olefsky JM and Gustafson TA: Interaction of a GRB-IR splice variant (a human GRB10 homolog) with the insulin and insulin-like growth factor I receptors. Evidence for a role in mitogenic signaling. J Biol Chem 271: 22506-2251, 1996. (Pubitemid 26304688)
8. Burgering BM and Coffer PJ: Protein kinase B(c-Akt) in phosphoinositol-3-Oh kinase signal transduction. Nature 376: 599-602, 1995.
9. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J and Kahn CR: Phosphotidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis and glucose transporter translocation. Mol Cell Biol 14: 4902-4911, 1994.
10. Dufourny B, Alblas J, van Teeffelen HA, van Schaik FM, van der Burg B, Steenbergh PH and Sussenbach JS: Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J Biol Chem 272: 31163-31167, 1997.
11. Liu HY, Chiang YC, Pan J, Chen J, Salvadore C, Audino DC, Badarinarayana V, Palaniswamy V, Anderson B and Denis CL: Characterization of CAF4 and CAF16 reveals a functional connection between the CCR4-NOT complex and a subset of SRB proteins of the RNA polymerase II holoenzyme. J Biol Chem 276: 7541-7548, 2001.
12. Collart MA: The NOT, SPT3, and MOT1 genes functionally interact to regulate transcription at core promoters. Mol Cell Biol 16: 6668-6676, 1996.
13. Denis CL and Chen J: The CCR4-NOT complex plays diverse roles in mRNA metabolism. Prog Nucleic Acid Res Mol Biol 73: 221-250, 2003.
14. Draper MP, Salvadore C and Denis CL: Identification of a mouse protein whose homolog in Saccharomyces cerevisiae is a component of the CCR4 transcriptional regulatory complex. Mol Cell Biol 15: 487-495, 1995.
15. Badarinarayana V, Chiang Y-C and Denis CL: Functional interaction of CCR4-NOT proteins with TATAA-binding protein (TBP) and its associated factors in yeast. Genetics 155: 1045-1054, 2000. (Pubitemid 30463417)
16. Schneider BL, Seufert W, Steiner B, Yang QH and Futcher AB: Use of polymerase chain reaction epitope tagging for protein tagging in Saccharomyces cerevisiae. Yeast 11: 1265-1274, 1995.
17. Benson JD, Benson M, Howley PM and Struhl K: Association of distinct yeast Not2 functional domains with components of Gcn5 histone acetylase and Ccr4 transcriptional regulatory complexes. EMBO J 17: 6714-6722, 1998. (Pubitemid 28521804)
18. 2+-dependent endonuclease-related proteins in higher eukaryotes, and characterization of orthologs of yCCR4 with a conserved leucine-rich repeat essential for hCAF1/hPOP2 binding. BMC Genomics 2: 9, 2001.
19. Chen J, Chiang YC and Denis CL: CCR4, a 3′-5′ poly(A) RNA and ssDNA exonuclease, is the catalytic component of the cytoplasmic deadenylase. EMBO J 21: 1414-1420, 2002. (Pubitemid 34246520)
20. Temme C, Zaessinger S, Meyer S, Simonelig M and Wahle E: A complex containing the CCR4 and CAF1 proteins is involved in mRNA deadenylation in Drosophila. EMBO J 21: 2862-2871, 2004. (Pubitemid 39013558)
21. Liu HY, Badrinarayan YV, Audino DC, Rappsiber J, Mann M and Denis CL: The NOT proteins are part of the CCR4 transcriptional complex and affect gene expression both positively and negatively. EMBO J 17: 1096-1106, 1998. (Pubitemid 28077663)
22. Albert TK, Lemaire M, van Berkum NL, Gentz R, Collart MA and Timmers HT: Isolation and characterization of human orthologs of yeast CCR4-NOT complex subunits. Nucleic Acids Res 28: 809-817, 2000. (Pubitemid 30068266)
23. Fidler C, Wainscoat JS and Boultwood J: The human POP2 gene: identification, sequencing, and mapping to the critical region of the 5q-syndrome. Genomics 56: 134-136, 1999. (Pubitemid 29107213)
24. Guehenneux F, Duret L, Callanan MB, Bouhas R, Hayette S, Berthet C, Samarut C, Rimokh R, Birot AM, Wang Q, Magaud JP and Rouault JP: Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle. Leukemia 11: 370-375, 1997.
25. Ikematsu N, Yoshida Y, Kawamura-Tsuzuku J, Ohsugi M, Onda M, Hirai M, Fujimoto J and Yamamoto T: Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases. Oncogene 18: 7432-7441, 1999.
26. Rouault JP, Prevot D, Berthet C, Birot AM, Billaud M, Magaud JP and Corbo L: Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex. J Biol Chem 273: 22563-22569, 1998.
27. Matsuda S, Rouault J, Magaud J and Berthet C: In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett 497: 67-72, 2001.
28. Rouault JP, Falette N, Guehenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C and Puisieux A: Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 14: 482-486, 1996.
29. Kozak M: An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol 115: 887-903, 1991.
30. Rogers S, Wells R and Rechsteiner M: Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234: 364-368, 1986. (Pubitemid 17181385)
31. Bai C, Richman R and Elledge SJ: Human cyclin F. EMBO J 13: 6087-6098, 1994.
32. Salama S, Hendricks KB and Thorner J: G1 cyclin degradation: the PEST motif of yeast Cln2 is necessary, but not sufficient, for rapid protein turnover. Mol Cell Biol 14: 7953-7966, 1994. (Pubitemid 24373544)
33. McClelland M, Chada K, Welsh J and Ralph D: Arbitrary primed PCR fingerprinting of RNA applied to mapping differentially expressed genes. In: State of the Science. Birkhauser Verlag, pp103-115, 1993.
34. Jackson JG, White MB and Yee D: Insulin receptor substrate-1 (IRS1) is the predominant signaling molecule activated by insulin-like growth factor (IGF1), insulin and Interleukin-4 (IL-4) in estrogen receptor positive human breast cancer cells. J Biol Chem 273: 994-1003, 1998.
35. Whitmarsh AJ, Yang SH, Su MS, Sharrocks AD and Davis RJ: Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol Cell Biol 17: 2360-2371, 1997.
36. Furlanetto RW, Harwell SE and Frick KK: Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro. Mol Endocrinol 8: 510-517, 1994. (Pubitemid 24114741)
37. Mawson A, Lai A, Carroll JS, Sergio CM, Mitchell CJ and Sarcevic B: Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1. Mol Cell Endocrinol 229: 161-173, 2005.
38. Zhang S, Li X, Burghardt R, Smith R III and Safe SH: Role of estrogen receptor (ER) (alpha) in insulin-like growth factor (IGF)-I-induced responses in MCF-7 breast cancer cells. J Mol Endocrinol 35: 433-447, 2005. (Pubitemid 43025570)
39. Murray JI, Whitfield ML, Trinklein ND, Myers RM, Brown PO and Botstein D: Diverse and specific gene expression responses to stresses in cultured human cells. Mol Biol Cell 15: 2361-2374, 2004. (Pubitemid 38580652)
40. Yee D, Jackson JG, Weng CN, Gooch JL and Lee AV: Molecular Mechanisms to Regulate the Activities of Insulin-Like Growth Factors. Takaro K, Hizuka N and Takahashi SI (eds). Elsevier, pp319-325, 1998.
41. Curran T and Morgan JI: Superinduction of c-fos by nerve growth factor in the presence of peripherally active benzodiazepines. Science 229: 1265-1268, 1985. (Pubitemid 15021677)
42. Shaulian E and Karin M: AP-1 as a regulator of cell life and death. Nat Cell Biol 4: E131-E136, 2002. (Pubitemid 34521026)
43. Angel P and Karin M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129-157, 1991.
44. Greenberg ME and Ziff EB: Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311: 433-438, 1984.
45. Raburn DJ, Hamil KG, Tsuruta JK, O'Brien DA and Hall SH: Stage-specific expression of B cell translocation gene 1 in rat testis. Endocrinology 136: 5769-5777, 1995.
46. Rouault JP, Rimokh R, Tessa C, Paranhos G, Ffrench M, Duret L, Garoccio M, Germain D, Samarut J and Magaud JP: BTG1, a member of a new family of antiproliferative genes. EMBO J 11: 1663-1670, 1992.
47. Tirone F: The gene PC3 (TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair? J Cell Physiol 187: 155-165, 2001.
48. Bogdan JA, Adams-Burton C, Pedicord DL, Sukovich DA, Benfield PA, Corjay MH, Stoltenborg JK and Dicker IB: Human carbon catabolite repressor protein (CCR4)-associative factor 1: cloning, expression and characterization of its interaction with the B-cell translocation protein BTG1. Biochem J 336: 471-481, 1998.
49. Kawamura-Tsuzuku J, Suzuki T, Yoshida Y and Yamamoto T: Nuclear localization of Tob is important for regulation of its antiproliferative activity. Oncogene 23: 6630-6638, 2004. (Pubitemid 39265526)
50. Prevot D, Morel AP, Voeltzel T, Rostan MC, Rimokh R, Magaud JP and Corbo L: Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway. J Biol Chem 276: 9640-9648, 2001.
51. Iwai K, Hirata K, Ishida T, Takeuchi S, Hirase T, Rikitake Y, Kojima Y, Inoue N, Kawashima S and Yokoyama M: An antiproliferative gene BTG1 regulates angiogenesis in vitro. Biochem Biophys Res Commun 316: 628-635, 2004.
52. Sasajima H, Nakagawa K and Yokosawa H: Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system. Eur J Biochem 269: 3596-3604, 2002. (Pubitemid 34989004)
53. Kuo ML, Duncavage EJ, Mathew R, den Besten W, Pei D, Naeve D, Yamamoto T, Cheng C, Sherr CJ and Roussel MF: Arf induces p53-dependent and -independent antiproliferative genes. Cancer Res 63: 1046-1053, 2003.
54. Yoshida NL, Miyashita T, U M, Yamada M, Reed JC, Sugita Y and Oshida T: Analysis of gene expression patterns during glucocorticoid-induced apoptosis using oligonucleotide arrays. Biochem Biophys Res Commun 293: 1254-1261, 2002.
55. Chang GT, Blok LJ, Steenbeek M, Veldscholte J, van Weerden WM, van Steenbrugge GJ and Brinkmann AO: Differentially expressed genes in androgen-dependent and -independent prostate carcinomas. Cancer Res 57: 4075-4081, 1997.